HMGB1 and breast cancer: To evaluate whether [Cu(DDC)2] NP can elicit ICD, a form of regulated cell death that stimulates adaptive immunity, we assessed three hallmark indicators of ICD using 4T1 breast cancer cells as the model system: surface exposure of CRT, release of HMGB1, and extracellular ATP secretion.